Suppr超能文献

侧方型cT3/4N0口腔鳞状细胞癌的对侧颈部转移

Contralateral neck metastasis in lateralized cT3/4N0 oral squamous cell carcinoma.

作者信息

Fang Qigen, Yuan Junhui, Huang Tao

机构信息

Department of Head Neck and Thyroid, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

出版信息

J Craniomaxillofac Surg. 2025 Mar;53(3):222-227. doi: 10.1016/j.jcms.2024.12.008. Epub 2024 Dec 9.

Abstract

Our goal was to investigate the pattern of contralateral lymphatic drainage (CLD) and contralateral neck failure (CNF) in cT3/4N0 oral cancer patients subjected to lymphoscintigraphy guided elective neck dissection (LSG-END) versus END. Patients were retrospectively enrolled and divided into two groups based on neck management. Pattern of CLD in LSG-END cohort was descriptively presented. Impact of LSG-END vs. END on CNF and overall survival was analyzed using Cox model. In total, 450 patients were included. In the LSG-END group, 54 patients exhibited CLD, resulting in an incidence of 23.5% and independently predicted by primary site, differentiation, tumor stage, and lymphovascular invasion. Contralateral levels I and II were the most involved site, and significantly influenced by primary site. In Cox model, patients treated with END had approximately double the risk of contralateral recurrence compared to those managed with LSG-END. Patients undergoing treatment with either END or LSG-END exhibited comparable OS rates. Among patients with cT3/4N0 oral cancer, CLD was observed in approximately one-quarter of the cohort. Although no additional overall survival advantage was identified, LSG-END proved to be more effective in controlling CNF compared to conventional END.

摘要

我们的目标是研究接受淋巴闪烁造影引导下选择性颈清扫术(LSG-END)与传统颈清扫术(END)的cT3/4N0口腔癌患者的对侧淋巴引流(CLD)模式和对侧颈部复发(CNF)情况。对患者进行回顾性纳入,并根据颈部处理方式分为两组。对LSG-END队列中的CLD模式进行了描述性呈现。使用Cox模型分析LSG-END与END对CNF和总生存期的影响。总共纳入了450例患者。在LSG-END组中,54例患者出现CLD,发生率为23.5%,且由原发部位、分化程度、肿瘤分期和淋巴管浸润独立预测。对侧Ⅰ区和Ⅱ区是最常受累的部位,且受原发部位的显著影响。在Cox模型中,接受END治疗的患者对侧复发风险约为接受LSG-END治疗患者的两倍。接受END或LSG-END治疗的患者总生存率相当。在cT3/4N0口腔癌患者中,约四分之一的队列观察到CLD。尽管未发现额外的总生存优势,但与传统END相比,LSG-END在控制CNF方面被证明更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验